Piramal Phytocare Limited - Due diligence report

A 360° intelligence report on Piramal Phytocare Limited: trust score, financial health, credit view, compliance, directors, growth and distr…

2001-06-27 Mumbai, Maharashtra Amalgamated Listed Active Compliant
Share
PP Piramal Phytocare Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Piramal Phytocare Limited — 360° Intelligence Report

Generated from MCA filings & public records
38/100
Trust Score
Caution Indicated

Piramal Phytocare Limited is assessed as Caution Indicated with a Trust Score of 38/100. Piramal Phytocare Limited is a public limited indian non-government company incorporated in 2001, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Piramal Phytocare Limited snapshot & full profile →

Financial Health › Caution
Overall Assessment CautionWeakNeutralGoodStrong Weak
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreCaution Indicated
38/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
5/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
15/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 1 satisfied (75.00 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Hdfc Bank Limited1 48.0 cr
Compliance Score: 5/100 Caution Indicated
  • Company status is "Amalgamated" - not Active.
  • Last balance sheet is for Mar 2019 - filings overdue.
  • Flagged by authority: BSE.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
RASHIDA QUAID NAJMI 01234567 Director 01/04/2018 6 yrs Approved
RAJESH RATANLAL LADDHA 01234567 Director 01/04/2018 6 yrs Approved
MANEESH SHARMA 01234567 Director 01/04/2018 6 yrs Approved
NAVNITLAL BHATIA 01234567 Director 01/04/2018 6 yrs Approved
GAUTAM BHAILAL DOSHI 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2019 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 0 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 70 · Distress 35
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Operating for 25+ years.
Distress signals & risk flags
Negative net worth.
Statutory filings appear overdue.
Adverse company status: Amalgamated.
Compliance score is weak (5/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence24/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment26/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view43/100
Limited indicators at present
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
05 Aug 2019
Last AGM held
Annual general meeting
31 Mar 2019
Latest balance sheet
Filed with ROC
02 Aug 2018
Director ceased
RASHIDA QUAID NAJMI
12 Apr 2017
Director appointed
RASHIDA QUAID NAJMI (Director)
21 Feb 2017
Director ceased
VANDANA JEEWANDAS SONAVARIA
22 Jul 2015
Director appointed
MANEESH SHARMA (Company Secretary)
10 Jul 2015
Director ceased
NEELESH KISHORE BHISE
15 Apr 2015
Charge satisfied
Hdfc Bank Limited
31 Jul 2013
Director ceased
NAVNITLAL BHATIA
21 May 2013
Director ceased
PRASHANT SURANA
19 May 2012
Director ceased
VANDANA JITENDRA CHABLANI
02 Feb 2012
Director appointed
RAJESH RATANLAL LADDHA (Director)
Director appointed
NAVNITLAL BHATIA (Director)
Director ceased
GOVERDHAN MEHTA
Director ceased
SANTHANAM NARAYANASWAMY
10

Key Observations

Auto-generated from the data above
Revenue grew 1.42 over the last 4 financial year(s).
Net profit margin moved from 2.1x to 24%.
5 active director(s) / partner(s); board looks stable and experienced.
All 1 registered charge(s) stand satisfied - past borrowings repaid.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a majority stake as per the FY 2019 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Sivasakthi Industrial Explosives Private Limited U24292TZ2008PTC014580 Salem, Tamil Nadu, India
Vilin Bio Med Limited L24230TG2005PLC046689 Khairatabad, Telangana, India
Aristonpharmanovatech U24232TG2012PTC083734 Hyderabad, Telangana, India
Raffles Green Pet India Private Limited U37200GJ2013PTC076748 Kheda, Gujarat, India
Surfactant Products Private Limited U24100GJ2012PTC071130 Ahmedabad, Gujarat, India
Strides U24290MH2003PTC138910 Mumbai, Maharashtra, India
Alchemist Group L72200DL1988PLC192643 Delhi, India
Indoaminesltd U24200MH1989PTC051084 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Piramal Phytocare Limited before audits and certifications: compliance score 5/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Piramal Phytocare Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Limited indicators at present. Growth score 70/100, margin trends, ownership structure and peer set for Piramal Phytocare Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 38/100, distress signals and MSME payment-delay disclosures - know whether Piramal Phytocare Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Piramal Phytocare Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Piramal Phytocare Limited an active company?

Piramal Phytocare Limited has MCA status “Amalgamated” with a compliance score of 5/100 (Caution Indicated).

Is Piramal Phytocare Limited financially healthy?

Piramal Phytocare Limited has a Financial Health Score of 15/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Piramal Phytocare Limited?

Its overall Trust Score is 38/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Piramal Phytocare Limited?

Promoters hold a majority stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Piramal Phytocare Limited have loans or charges against its assets?

No open charges - all 1 registered charge(s) stand satisfied, indicating past borrowings were repaid.

Is Piramal Phytocare Limited up to date with its ROC filings?

Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 5/100 (Caution Indicated).

Is it risky to lend to Piramal Phytocare Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.